survival benefit

ZURICH, Switzerland, March 19, 2026 AL-S Pharma AG announced new Phase 2 clinical data for its lead investigational therapy...

Basel, 8 December 2025 — Roche has reported three-year follow-up findings from the pivotal phase III STARGLO study, demonstrating...